| # | Drug | Count |
|---|---|---|
| 0 | INTERFERON BETA-1A | 1681 |
| 1 | FINGOLIMOD HCL | 748 |
| 2 | ADALIMUMAB | 407 |
| 3 | PREDNISONE | 402 |
| 4 | ETANERCEPT | 328 |
| 5 | METHOTREXATE SODIUM | 311 |
| 6 | GLATIRAMER ACETATE | 291 |
| 7 | OCRELIZUMAB | 279 |
| 8 | METHOTREXATE | 276 |
| 9 | GABAPENTIN | 274 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CYCLOSERINE | 56 | 0.0242 |
| 1 | PRETOMANID | 16 | 0.0211 |
| 2 | BEDAQUILINE FUMARATE | 26 | 0.0180 |
| 3 | ETHAMBUTOL HYDROCHLORIDE | 41 | 0.0151 |
| 4 | CLOFAZIMINE | 67 | 0.0103 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 48 | 0.0094 |
| 6 | INTERFERON BETA-1A | 1681 | 0.0087 |
| 7 | FINGOLIMOD HCL | 748 | 0.0087 |
| 8 | PYRAZINAMIDE | 65 | 0.0069 |
| 9 | OFATUMUMAB | 212 | 0.0063 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interferon beta [EPC] | 1681 |
| 1 | Corticosteroid [EPC] | 801 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 684 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 594 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 583 |
| 5 | Benzodiazepine [EPC] | 313 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 282 |
| 7 | Proton Pump Inhibitor [EPC] | 269 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 258 |
| 9 | Vitamin C [EPC] | 196 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon beta [EPC] | 1681 | 0.0087 |
| 1 | Antimycobacterial [EPC] | 155 | 0.0064 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 87 | 0.0063 |
| 3 | Oxazolidinone Antibacterial [EPC] | 186 | 0.0061 |
| 4 | Pyrimidine Synthesis Inhibitor [EPC] | 258 | 0.0057 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 85 | 0.0044 |
| 6 | Rifamycin Antimycobacterial [EPC] | 14 | 0.0040 |
| 7 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0030 |
| 8 | Sympathomimetic-like Agent [EPC] | 81 | 0.0025 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 684 | 0.0022 |